LUPIN LIMITED vs TORRENT PHARMACEUTICALS L
A side-by-side comparison of LUPIN LIMITED (LUPIN) and TORRENT PHARMACEUTICALS L (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, LUPIN LIMITED leads LUPIN vs TORNTPHARM on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation40
- Profitability22
- Growth20
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
LUPIN takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
EvenHow efficiently each company turns capital and sales into profit. Higher is better.
Growth
LUPIN takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
LUPIN takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 34.3% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.8%"]
- − []
- + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 67.6%"]
- − ["Stock is trading at 20.67 times its book value", "Company has a high debt to equity ratio of 1.79."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.